Cargando…

PRMT5-mediated regulatory arginine methylation of RIPK3

The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase activation or RIPK3-dependent necroptotic cell dea...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Chanchal, Martinez-Val, Ana, Niedenthal, Rainer, Olsen, Jesper Velgaard, Kotlyarov, Alexey, Bekker-Jensen, Simon, Gaestel, Matthias, Menon, Manoj B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852244/
https://www.ncbi.nlm.nih.gov/pubmed/36658119
http://dx.doi.org/10.1038/s41420-023-01299-z
_version_ 1784872573383737344
author Chauhan, Chanchal
Martinez-Val, Ana
Niedenthal, Rainer
Olsen, Jesper Velgaard
Kotlyarov, Alexey
Bekker-Jensen, Simon
Gaestel, Matthias
Menon, Manoj B.
author_facet Chauhan, Chanchal
Martinez-Val, Ana
Niedenthal, Rainer
Olsen, Jesper Velgaard
Kotlyarov, Alexey
Bekker-Jensen, Simon
Gaestel, Matthias
Menon, Manoj B.
author_sort Chauhan, Chanchal
collection PubMed
description The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase activation or RIPK3-dependent necroptotic cell death in a context-dependent manner. Using a mass spectrometry-based screen to find new components of the ripoptosome/necrosome, we discovered the protein-arginine methyltransferase (PRMT)-5 as a direct interaction partner of RIPK1. Interestingly, RIPK3 but not RIPK1 was then found to be a target of PRMT5-mediated symmetric arginine dimethylation. A conserved arginine residue in RIPK3 (R486 in human, R415 in mouse) was identified as the evolutionarily conserved target for PRMT5-mediated symmetric dimethylation and the mutations R486A and R486K in human RIPK3 almost completely abrogated its methylation. Rescue experiments using these non-methylatable mutants of RIPK3 demonstrated PRMT5-mediated RIPK3 methylation to act as an efficient mechanism of RIPK3-mediated feedback control on RIPK1 activity and function. Therefore, this study reveals PRMT5-mediated RIPK3 methylation as a novel modulator of RIPK1-dependent signaling.
format Online
Article
Text
id pubmed-9852244
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98522442023-01-21 PRMT5-mediated regulatory arginine methylation of RIPK3 Chauhan, Chanchal Martinez-Val, Ana Niedenthal, Rainer Olsen, Jesper Velgaard Kotlyarov, Alexey Bekker-Jensen, Simon Gaestel, Matthias Menon, Manoj B. Cell Death Discov Article The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase activation or RIPK3-dependent necroptotic cell death in a context-dependent manner. Using a mass spectrometry-based screen to find new components of the ripoptosome/necrosome, we discovered the protein-arginine methyltransferase (PRMT)-5 as a direct interaction partner of RIPK1. Interestingly, RIPK3 but not RIPK1 was then found to be a target of PRMT5-mediated symmetric arginine dimethylation. A conserved arginine residue in RIPK3 (R486 in human, R415 in mouse) was identified as the evolutionarily conserved target for PRMT5-mediated symmetric dimethylation and the mutations R486A and R486K in human RIPK3 almost completely abrogated its methylation. Rescue experiments using these non-methylatable mutants of RIPK3 demonstrated PRMT5-mediated RIPK3 methylation to act as an efficient mechanism of RIPK3-mediated feedback control on RIPK1 activity and function. Therefore, this study reveals PRMT5-mediated RIPK3 methylation as a novel modulator of RIPK1-dependent signaling. Nature Publishing Group UK 2023-01-19 /pmc/articles/PMC9852244/ /pubmed/36658119 http://dx.doi.org/10.1038/s41420-023-01299-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Chauhan, Chanchal
Martinez-Val, Ana
Niedenthal, Rainer
Olsen, Jesper Velgaard
Kotlyarov, Alexey
Bekker-Jensen, Simon
Gaestel, Matthias
Menon, Manoj B.
PRMT5-mediated regulatory arginine methylation of RIPK3
title PRMT5-mediated regulatory arginine methylation of RIPK3
title_full PRMT5-mediated regulatory arginine methylation of RIPK3
title_fullStr PRMT5-mediated regulatory arginine methylation of RIPK3
title_full_unstemmed PRMT5-mediated regulatory arginine methylation of RIPK3
title_short PRMT5-mediated regulatory arginine methylation of RIPK3
title_sort prmt5-mediated regulatory arginine methylation of ripk3
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852244/
https://www.ncbi.nlm.nih.gov/pubmed/36658119
http://dx.doi.org/10.1038/s41420-023-01299-z
work_keys_str_mv AT chauhanchanchal prmt5mediatedregulatoryargininemethylationofripk3
AT martinezvalana prmt5mediatedregulatoryargininemethylationofripk3
AT niedenthalrainer prmt5mediatedregulatoryargininemethylationofripk3
AT olsenjespervelgaard prmt5mediatedregulatoryargininemethylationofripk3
AT kotlyarovalexey prmt5mediatedregulatoryargininemethylationofripk3
AT bekkerjensensimon prmt5mediatedregulatoryargininemethylationofripk3
AT gaestelmatthias prmt5mediatedregulatoryargininemethylationofripk3
AT menonmanojb prmt5mediatedregulatoryargininemethylationofripk3